ClinConnect ClinConnect Logo
Search / Trial NCT06756542

Evaluating the Use of Artificial Intelligence to Improve Family Conversations for Intensive Care Patients and Their Families

Launched by DAVY VAN DE SANDE · Jan 2, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Intensive Care Artificial Intelligence Large Language Models Administration Reduction Patient Satisfaction

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can help improve conversations between doctors and families of patients in the intensive care unit (ICU). Right now, doctors spend a lot of time writing notes after talking with families, which can take time away from caring for patients. The trial will see if AI can quickly create easy-to-understand summaries of these conversations, making it easier for doctors to document and for families to grasp important medical information.

To participate in the study, families must have a loved one admitted to the adult ICU, and all family members involved in the conversation must be 18 years or older and able to speak Dutch. All participants, including family members and healthcare professionals, will need to sign consent forms to take part. If you decide to participate, you can expect to be part of a conversation where the AI helps summarize what is discussed, potentially making it less stressful and more informative for everyone involved.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed-consent is signed by all participating family members during the conversation.
  • Informed-consent is signed by the ICU healthcare professionals.
  • The patient of the family must be admitted to the adult ICU.
  • All participating family members must be 18 years or older.
  • The family conversation must be in Dutch.
  • Exclusion Criteria:
  • Trained to interpret medical jargon and/or intensive care terminology specifically
  • Difficulty reading and/or writing in the Dutch language

About Davy Van De Sande

Davy van de Sande is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Davy leads initiatives that encompass a wide range of therapeutic areas, ensuring comprehensive trial design and execution. Collaborating with leading healthcare professionals and institutions, Davy is dedicated to fostering transparency and integrity within the clinical research landscape, ultimately contributing to the development of safe and effective treatments for diverse patient populations.

Locations

Rotterdam, Zuid Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Diederik Gommers, MD PhD

Study Director

Intensive Care Adults, Erasmus University Medical Center, Rotterdam, the Netherlands

Michel E. van Genderen, MD PhD

Principal Investigator

Intensive Care Adults, Erasmus University Medical Center, Rotterdam, the Netherlands

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported